Sanofi (0O59) Ratios
Sanofi Ratios
GB:0O59's free cash flow for Q2 2026 was $3.35B. For the 2026 fiscal year, GB:0O59's free cash flow was decreased by $-1.30B and operating cash flow was $4.64B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.09 | 1.46 | 1.27 | 1.42 | 1.44 |
| Quick Ratio | 1.09 | 1.14 | 0.87 | 1.05 | 1.03 |
| Cash Ratio | 0.26 | 0.26 | 0.36 | 0.53 | 0.47 |
| Solvency Ratio | 0.24 | 0.15 | 0.16 | 0.21 | 0.17 |
| Operating Cash Flow Ratio | 0.38 | 0.31 | 0.42 | 0.44 | 0.49 |
| Short-Term Operating Cash Flow Coverage | 2.48 | 2.16 | 5.02 | 2.52 | 3.31 |
| Net Current Asset Value | $ -24.14B | $ -12.35B | $ -21.44B | $ -17.46B | $ -20.56B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.13 | 0.15 | 0.17 | 0.19 |
| Debt-to-Equity Ratio | 0.28 | 0.23 | 0.25 | 0.28 | 0.33 |
| Debt-to-Capital Ratio | 0.22 | 0.19 | 0.20 | 0.22 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.17 | 0.13 | 0.16 | 0.17 | 0.20 |
| Financial Leverage Ratio | 1.78 | 1.71 | 1.71 | 1.69 | 1.75 |
| Debt Service Coverage Ratio | 2.30 | 2.18 | 3.92 | 2.45 | 2.73 |
| Interest Coverage Ratio | 15.33 | 24.24 | 24.87 | 33.37 | 22.45 |
| Debt to Market Cap | 0.18 | 0.14 | 0.15 | 0.17 | 0.18 |
| Interest Debt Per Share | 17.17 | 14.79 | 15.13 | 17.26 | 18.18 |
| Net Debt to EBITDA | 1.04 | 0.90 | 0.88 | 0.65 | 1.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 72.07% | 70.21% | 69.30% | 70.55% | 68.73% |
| EBIT Margin | 14.56% | 20.03% | 19.75% | 25.76% | 21.86% |
| EBITDA Margin | 26.71% | 26.34% | 26.94% | 32.49% | 28.72% |
| Operating Profit Margin | 20.54% | 32.63% | 31.57% | 32.62% | 20.74% |
| Pretax Profit Margin | 12.89% | 15.26% | 14.88% | 24.79% | 20.01% |
| Net Profit Margin | 16.72% | 12.55% | 13.14% | 20.77% | 15.89% |
| Continuous Operations Profit Margin | 10.65% | 12.54% | 12.40% | 20.06% | 16.03% |
| Net Income Per EBT | 129.78% | 82.27% | 88.31% | 83.78% | 79.41% |
| EBT Per EBIT | 62.73% | 46.77% | 47.11% | 75.99% | 96.44% |
| Return on Assets (ROA) | 6.16% | 4.19% | 4.27% | 6.61% | 5.18% |
| Return on Equity (ROE) | 10.95% | 7.17% | 7.29% | 11.19% | 9.06% |
| Return on Capital Employed (ROCE) | 9.75% | 13.94% | 12.69% | 12.80% | 8.21% |
| Return on Invested Capital (ROIC) | 7.70% | 10.99% | 10.35% | 9.92% | 6.36% |
| Return on Tangible Assets | 13.19% | 8.33% | 10.24% | 15.17% | 12.26% |
| Earnings Yield | 7.74% | 4.74% | 4.81% | 7.44% | 5.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.23 | 4.17 | 3.72 | 3.75 | 4.00 |
| Payables Turnover | 0.57 | 1.75 | 1.72 | 1.74 | 1.98 |
| Inventory Turnover | 0.00 | 1.40 | 1.31 | 1.32 | 1.41 |
| Fixed Asset Turnover | 4.06 | 3.82 | 3.48 | 3.45 | 3.27 |
| Asset Turnover | 0.37 | 0.33 | 0.33 | 0.32 | 0.33 |
| Working Capital Turnover Ratio | 5.83 | 4.45 | 4.95 | 4.14 | 3.28 |
| Cash Conversion Cycle | -555.00 | 139.61 | 165.65 | 163.34 | 166.71 |
| Days of Sales Outstanding | 86.30 | 87.60 | 98.02 | 97.32 | 91.19 |
| Days of Inventory Outstanding | 0.00 | 260.88 | 279.59 | 275.54 | 259.65 |
| Days of Payables Outstanding | 641.30 | 208.88 | 211.96 | 209.52 | 184.12 |
| Operating Cycle | 86.30 | 348.48 | 377.61 | 372.86 | 350.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.81 | 7.26 | 8.20 | 8.41 | 8.40 |
| Free Cash Flow Per Share | 7.36 | 4.70 | 6.90 | 6.65 | 6.77 |
| Dividend Paid and CapEx Coverage Ratio | 1.65 | 1.15 | 1.69 | 1.65 | 1.74 |
| Capital Expenditure Coverage Ratio | 6.10 | 2.84 | 6.34 | 4.78 | 5.15 |
| Operating Cash Flow Coverage Ratio | 0.53 | 0.51 | 0.56 | 0.50 | 0.47 |
| Operating Cash Flow to Sales Ratio | 0.23 | 0.21 | 0.25 | 0.26 | 0.27 |
| Free Cash Flow Yield | 8.90% | 5.02% | 7.69% | 7.40% | 7.64% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.92 | 21.35 | 20.81 | 13.44 | 17.83 |
| Price-to-Sales (P/S) Ratio | 2.16 | 2.65 | 2.73 | 2.79 | 2.83 |
| Price-to-Book (P/B) Ratio | 1.41 | 1.51 | 1.52 | 1.50 | 1.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.23 | 19.93 | 13.01 | 13.51 | 13.08 |
| Price-to-Operating Cash Flow Ratio | 9.39 | 12.92 | 10.95 | 10.69 | 10.54 |
| Price-to-Earnings Growth (PEG) Ratio | 0.28 | 11.50 | -0.58 | 0.39 | -0.36 |
| Enterprise Value Multiple | 9.13 | 10.95 | 11.02 | 9.24 | 10.96 |
| Enterprise Value | 113.89B | 127.77B | 122.06B | 120.95B | 123.26B |
| EV to EBITDA | 9.13 | 10.95 | 11.02 | 9.24 | 10.96 |
| EV to Sales | 2.44 | 2.89 | 2.97 | 3.00 | 3.15 |
| EV to Free Cash Flow | 12.67 | 21.71 | 14.13 | 14.53 | 14.54 |
| EV to Operating Cash Flow | 10.59 | 14.07 | 11.90 | 11.49 | 11.71 |
| Tangible Book Value Per Share | 3.40 | 9.46 | 0.50 | 2.89 | -0.34 |
| Shareholders’ Equity Per Share | 58.49 | 61.94 | 59.15 | 59.74 | 54.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.18 | 0.17 | 0.19 | 0.20 |
| Revenue Per Share | 38.28 | 35.39 | 32.84 | 32.19 | 31.28 |
| Net Income Per Share | 6.40 | 4.44 | 4.31 | 6.69 | 4.97 |
| Tax Burden | 1.30 | 0.82 | 0.88 | 0.84 | 0.79 |
| Interest Burden | 0.89 | 0.76 | 0.75 | 0.96 | 0.92 |
| Research & Development to Revenue | 0.17 | 0.17 | 0.16 | 0.16 | 0.15 |
| SG&A to Revenue | 0.22 | 0.21 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Income Quality | 2.18 | 1.65 | 2.03 | 1.26 | 1.69 |
Currency in EUR
